Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
1.410
-0.030 (-2.08%)
Mar 6, 2026, 4:00 PM EST - Market closed
Catheter Precision Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.73 | 0.42 | 0.44 | 0.01 | 0.02 | 0.26 |
| Revenue Growth (YoY) | 82.96% | -4.98% | 3057.14% | -36.36% | -91.51% | - |
| Cost of Revenue | 0.05 | 0.04 | 0.03 | 0.16 | 1.56 | 2.17 |
| Gross Profit | 0.68 | 0.38 | 0.41 | -0.15 | -1.54 | -1.91 |
| Selling, General & Admin | 12.42 | 11.35 | 17.12 | 16.25 | 15.48 | 24.53 |
| Research & Development | 0.63 | 0.27 | 0.48 | 6.39 | 12.25 | 8.96 |
| Operating Expenses | 13.04 | 11.62 | 17.6 | 22.64 | 27.73 | 33.49 |
| Operating Income | -12.37 | -11.24 | -17.19 | -22.79 | -29.27 | -35.4 |
| Interest Expense | -0.25 | -0.09 | - | - | - | - |
| Interest & Investment Income | 0.07 | 0.08 | 0.35 | - | - | - |
| Other Non Operating Income (Expenses) | -1.41 | -2.25 | 7.2 | 0.1 | -0.01 | 0.09 |
| EBT Excluding Unusual Items | -13.96 | -13.5 | -9.64 | -22.69 | -29.28 | -35.31 |
| Merger & Restructuring Charges | - | - | - | -4.17 | - | - |
| Impairment of Goodwill | - | - | -60.93 | - | - | - |
| Other Unusual Items | - | - | - | - | 2.02 | - |
| Pretax Income | -15.93 | -13.5 | -70.57 | -26.86 | -27.26 | -35.31 |
| Income Tax Expense | 1.55 | 3.14 | - | 0 | 0 | 0.01 |
| Earnings From Continuing Operations | -17.48 | -16.64 | -70.57 | -26.87 | -27.26 | -35.32 |
| Earnings From Discontinued Operations | - | - | - | - | 2.19 | -0.73 |
| Net Income | -17.03 | -16.64 | -70.57 | -26.87 | -25.07 | -36.05 |
| Preferred Dividends & Other Adjustments | 5.16 | 5.16 | 0.8 | - | - | - |
| Net Income to Common | -22.19 | -21.8 | -71.37 | -26.87 | -25.07 | -36.05 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | - | - | - |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | - | - | - |
| Shares Change (YoY) | 1292.59% | 493.90% | - | - | - | - |
| EPS (Basic) | -28.39 | -126.92 | -2467.83 | - | - | - |
| EPS (Diluted) | -28.39 | -126.92 | -2467.83 | - | - | - |
| Free Cash Flow | -9.67 | -9.34 | -20.7 | -22.59 | -27.89 | -28.37 |
| Free Cash Flow Per Share | -12.37 | -54.37 | -715.57 | - | - | - |
| Gross Margin | 92.60% | 90.00% | 93.21% | - | - | - |
| Operating Margin | -1693.97% | -2676.91% | -3888.01% | -162778.57% | -133027.27% | -13668.34% |
| Profit Margin | -3039.86% | -5190.71% | -16147.51% | -191892.86% | -113954.55% | -13916.99% |
| Free Cash Flow Margin | -1323.97% | -2223.33% | -4682.13% | -161321.43% | -126772.73% | -10954.05% |
| EBITDA | -10.25 | -9.13 | -15.11 | -22.37 | -28.1 | -33.44 |
| D&A For EBITDA | 2.12 | 2.11 | 2.08 | 0.42 | 1.17 | 1.97 |
| EBIT | -12.37 | -11.24 | -17.19 | -22.79 | -29.27 | -35.4 |
| Revenue as Reported | - | - | - | - | - | 0.26 |
Source: S&P Capital IQ. Standard template. Financial Sources.